NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.

عرض إصدارات أخرى (1)

BACKGROUND: Both oxaliplatin/capecitabine-based chemoradiation (OXCAP-RT) and carboplatin-paclitaxel based radiation (CarPac-RT) are active regimens in oesophageal adenocarcinoma, but no randomised study has compared their efficacy and toxicity. This randomised phase II "pick a winner" tri...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Mukherjee, S, Hurt, C, Gwynne, S, Bateman, A, Gollins, S, Radhakrishna, G, Hawkins, M, Canham, J, Lewis, W, Grabsch, H, Sharma, R, Wade, W, Maggs, R, Tranter, B, Roberts, A, Sebag-Montefiore, D, Maughan, T, Griffiths, G, Crosby, T
التنسيق: Journal article
اللغة:English
منشور في: BioMed Central 2015

مواد مشابهة